FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use ...United Arab Emirates

CNBC - Economy
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Ozempic's expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a gradual loss of kidney function.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use )

Also on site :



Latest News